Heyholder
‹ Activism Filings

ARIBIOLAB Q3 operating loss of KRW 1.7 billion, cumulative revenue of KRW 0.2 billion

ARIBIOLAB· Periodic Report

AI summary · Not investment advice

Aribio Lab sold KRW 0.2 billion from January to September, and lost KRW 1.7 billion from its main business in Q3, versus a KRW 3.4 billion loss a year earlier.

Operating profit · 3 months

KRW -1.7 billion

Key facts

Net income (3 months)
KRW -2.0 billion
Period
Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
Revenue (year to date)
KRW 173.2 millionNo revenue figure for the current 3 months in the source
Operating profit (prior-year 3 months)
KRW -3.4 billion
Operating profit (year to date)
KRW -5.8 billion
Net income (prior-year 3 months)
KRW -3.8 billion
Net income (year to date)
KRW -6.7 billion

Commentary

AI commentary · Not investment advice

What happened

Ariobiolab filed its report for the third quarter of 2026. On a standalone basis, sales for January to September total KRW 173.16 million. Sales for the latest 3 months alone are not given in the filing.

In the company's terms

Operating profit (profit from the core business) was KRW -1.67480 billion for the latest 3 months. The same period a year earlier was KRW -3.42072 billion. The year-to-date figure is KRW -5.83906 billion.

What changes for shareholders

Net income (the final profit after all costs and taxes) was KRW -1.96117 billion for the latest 3 months. The same period a year earlier was KRW -3.75622 billion. The year-to-date figure is KRW -6.69691 billion.

Comments

No comments yet

Comments from shareholders will appear here.